ArticleDrug design, development and therapy2015

A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.

Kusum Rathore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.